Search Results 431-440 of 14940 for alt

1. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

   ALT or AST \>3 times upper limit of normal (ULN) for the reference range, as determined by the central laboratory at screening visit. Patients with NAFLD ...

2. Toxicology and Pharmacology Shared Resource - Department of Molecular Medicine - Mayo Clinic Research

   ... (ALT) U/L, aspartate aminotransferase (AST) U/L, total bilirubin (TBIL) mg/dL, albumin (ALB) g/dL and total protein (TP) g/dL. To run this test, 150 µL of ...

3. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

   AST and ALT ≤2 x upper limit of normal (ULN);. NOTE: If baseline liver disease, Child Pugh score not exceeding Class A. Total bilirubin ≤.5 x ULN;; INR/PT ...

4. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

   Serum ALT/AST ≤ 2.5 x ULN; Total bilirubin ≤ 1.5 mg/dl, except in subjects with Gilbert's syndrome. Cardiac ejection fraction ≥ 50%, no evidence of ...

5. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... ALT ≤ 2.5 times ULN is acceptable; Estimated creatinine clearance of ≥ 30 mL/min, calculated using the formula of Cockroft and Gault; Female patients of ...

6. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

   * Alanine aminotransferase (ALT) and aspartate transaminase (AST) =\< 3 x ULN (=\< 5 x ULN for patients with liver involvement), obtained =\< 14 days prior ...

7. Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System - Mayo Clinic

   AST and ALT < 2 times ULN for age; Shortening fraction of ≥ 27% by echocardiogram; Ejection fraction of ≥ 47% by radionuclide angiogram; No evidence of ...

8. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Total bilirubin, AST, ALT, and alkaline phosphatase levels <2 times the upper limit of normal; Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet ...

9. Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery - Mayo Clinic

   ULN: ______ ALT ______ Date: ______. Serum creatinine ≤ 1.5 X institutional ULN and creatinine clearance ≥ 60 ml/min. ULN: ______ Creatinine ...

10. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

    ALT or AST > 5 times the upper limit of normal. Estimated glomerular filtration rate (eGFR) < 30 mL/min (including patients receiving hemodialysis or ...